TY - JOUR
T1 - Effect of vitamin D3 on prostaglandin E2 synthesis in osteoblast-like cells
AU - Suzuki, A.
AU - Tokuda, H.
AU - Kotoyori, J.
AU - Ito, Y.
AU - Oiso, Y.
AU - Kozawa, O.
N1 - Funding Information:
This investigation was supportedi n part by a Grant-in-Aid for scientific researchf rom the Ministry of Education, Science, and Culture of Japan.
PY - 1994/7
Y1 - 1994/7
N2 - We previously showed that prostaglandin (PG) F2α stimulates PGE2 synthesis in osteoblast-like MC3T3-E1 cells, and that the activation of protein kinase C (PKC) amplifies the effect of PGF2α through the potentiation of phospholipase A2 activity (H. Tokuda, Y. Oiso and O. Kozawa, J Cell Biochem. 48: 262-268, 1992). In the present study, we investigated the effects of vitamin D3 on PGF2α-induced PGE2 synthesis in MC3T3-E1 cells. The pretreatment with 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], an active form of vitamin D3, significantly inhibited the PGF2α-induced PGE2 synthesis in a dose-dependent manner in the range between 1 pM and 1 nM. This inhibitory effect of 1,25-(OH)2D3 was dependent on the time of pretreatment up to 8 h. On the contrary, the pretreatment with 24,25-dihydroxyvitamin D3, an inactive form of vitamin D3, had little effect on the PGF2α-induced PGE2 synthesis in these cells. However, the pretreatment with 1,25-(OH)2D3 no longer affected the amplification of PGF2α-induced PGE2 synthesis by 12-O-tetradecanoylphorbol-13-acetate, a PKC activator. These results strongly suggest that 1,25-(OH)2D3 inhibits PGF2α-induced PGE2 synthesis in osteoblast-like cells, however, the activation of PKC reverses this inhibitory effect of 1,25-(OH)2D3.
AB - We previously showed that prostaglandin (PG) F2α stimulates PGE2 synthesis in osteoblast-like MC3T3-E1 cells, and that the activation of protein kinase C (PKC) amplifies the effect of PGF2α through the potentiation of phospholipase A2 activity (H. Tokuda, Y. Oiso and O. Kozawa, J Cell Biochem. 48: 262-268, 1992). In the present study, we investigated the effects of vitamin D3 on PGF2α-induced PGE2 synthesis in MC3T3-E1 cells. The pretreatment with 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], an active form of vitamin D3, significantly inhibited the PGF2α-induced PGE2 synthesis in a dose-dependent manner in the range between 1 pM and 1 nM. This inhibitory effect of 1,25-(OH)2D3 was dependent on the time of pretreatment up to 8 h. On the contrary, the pretreatment with 24,25-dihydroxyvitamin D3, an inactive form of vitamin D3, had little effect on the PGF2α-induced PGE2 synthesis in these cells. However, the pretreatment with 1,25-(OH)2D3 no longer affected the amplification of PGF2α-induced PGE2 synthesis by 12-O-tetradecanoylphorbol-13-acetate, a PKC activator. These results strongly suggest that 1,25-(OH)2D3 inhibits PGF2α-induced PGE2 synthesis in osteoblast-like cells, however, the activation of PKC reverses this inhibitory effect of 1,25-(OH)2D3.
UR - http://www.scopus.com/inward/record.url?scp=0028179576&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028179576&partnerID=8YFLogxK
U2 - 10.1016/0952-3278(94)90174-0
DO - 10.1016/0952-3278(94)90174-0
M3 - Article
C2 - 7938095
AN - SCOPUS:0028179576
SN - 0952-3278
VL - 51
SP - 27
EP - 31
JO - Prostaglandins, Leukotrienes and Essential Fatty Acids
JF - Prostaglandins, Leukotrienes and Essential Fatty Acids
IS - 1
ER -